| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Apr 16, 2024 | Option Exercise | $4.40 | 62,500 | 274,907 | 1,241,679 | Apr 18, 2024, 05:12 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Apr 17, 2024 | Option Exercise | $4.27 | 60,624 | 258,599 | 1,254,179 | Apr 18, 2024, 05:12 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Mar 12, 2024 | Sale | $5.51 | 62,500 | 344,625 | 1,216,679 | Mar 14, 2024, 07:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Mar 13, 2024 | Sale | $5.75 | 62,500 | 359,065 | 1,229,179 | Mar 14, 2024, 07:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Feb 15, 2024 | Option Exercise | $12.43 | 7,172 | 89,148 | 1,179,179 | Feb 16, 2024, 07:59 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Feb 13, 2024 | Sale | $5.28 | 62,500 | 329,810 | 1,198,851 | Feb 15, 2024, 06:00 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Feb 14, 2024 | Sale | $5.51 | 62,500 | 344,675 | 1,211,351 | Feb 15, 2024, 06:00 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Feb 09, 2024 | Option Exercise | $10.09 | 2,512 | 25,346 | 1,161,351 | Feb 13, 2024, 07:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Jan 17, 2024 | Option Exercise | $5.43 | 62,500 | 339,597 | 1,006,014 | Jan 18, 2024, 06:37 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Jan 16, 2024 | Option Exercise | $5.51 | 62,500 | 344,410 | 993,514 | Jan 18, 2024, 06:37 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Dec 12, 2023 | Option Exercise | $4.29 | 62,500 | 268,118 | 968,514 | Dec 14, 2023, 06:53 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Dec 13, 2023 | Option Exercise | $4.37 | 62,500 | 273,020 | 981,014 | Dec 14, 2023, 06:53 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Nov 14, 2023 | Option Exercise | $3.86 | 62,500 | 241,192 | 950,686 | Nov 16, 2023, 06:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Nov 15, 2023 | Sale | $4.56 | 69,672 | 317,731 | 963,186 | Nov 16, 2023, 06:54 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Oct 10, 2023 | Sale | $4.16 | 62,500 | 260,012 | 925,686 | Oct 12, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Oct 11, 2023 | Sale | $4.07 | 62,500 | 254,563 | 938,186 | Oct 12, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Sep 12, 2023 | Sale | $4.70 | 62,500 | 293,882 | 900,686 | Sep 14, 2023, 06:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Sep 13, 2023 | Sale | $4.81 | 62,500 | 300,568 | 913,186 | Sep 14, 2023, 06:26 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Aug 15, 2023 | Sale | $5.33 | 67,227 | 358,484 | 875,686 | Aug 17, 2023, 06:35 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Aug 16, 2023 | Sale | $4.89 | 62,500 | 305,767 | 888,186 | Aug 17, 2023, 06:35 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Jul 18, 2023 | Sale | $6.78 | 62,500 | 424,052 | 855,413 | Jul 19, 2023, 07:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Jul 19, 2023 | Sale | $7.55 | 62,500 | 471,598 | 867,913 | Jul 19, 2023, 07:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Jun 13, 2023 | Option Exercise | $5.30 | 62,500 | 331,557 | 830,413 | Jun 15, 2023, 07:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Jun 14, 2023 | Option Exercise | $5.36 | 62,500 | 335,087 | 842,913 | Jun 15, 2023, 07:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | May 15, 2023 | Option Exercise | $5.60 | 4,760 | 26,656 | 790,159 | May 17, 2023, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Feb 04, 2022 | Option Exercise | $11.40 | 678 | 7,729 | 590,380 | Apr 28, 2023, 04:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Feb 15, 2023 | Option Exercise | $8.44 | 1,258 | 10,618 | 794,310 | Feb 17, 2023, 05:15 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Feb 01, 2023 | Option Exercise | $8.55 | 2,669 | 22,820 | 795,568 | Feb 03, 2023, 05:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Nov 15, 2022 | Option Exercise | $11.86 | 1,065 | 12,631 | 586,572 | Nov 17, 2022, 06:45 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Aug 15, 2022 | Option Exercise | $12.96 | 1,065 | 13,802 | 587,637 | Aug 17, 2022, 06:33 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | May 16, 2022 | Option Exercise | $5.67 | 1,069 | 6,061 | 588,702 | May 18, 2022, 07:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | Chief Financial Officer | Feb 04, 2022 | Option Exercise | $11.40 | 678 | 7,729 | 589,771 | Feb 08, 2022, 09:07 PM |
Menu